307 related articles for article (PubMed ID: 22222211)
1. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.
Gnirss K; Kühl A; Karsten C; Glowacka I; Bertram S; Kaup F; Hofmann H; Pöhlmann S
Virology; 2012 Mar; 424(1):3-10. PubMed ID: 22222211
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
[TBL] [Abstract][Full Text] [Related]
3. Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.
González-Hernández M; Müller A; Hoenen T; Hoffmann M; Pöhlmann S
Virology; 2019 Jun; 532():22-29. PubMed ID: 30999160
[TBL] [Abstract][Full Text] [Related]
4. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.
Misasi J; Chandran K; Yang JY; Considine B; Filone CM; Côté M; Sullivan N; Fabozzi G; Hensley L; Cunningham J
J Virol; 2012 Mar; 86(6):3284-92. PubMed ID: 22238307
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B & L are not required for ebola virus replication.
Marzi A; Reinheckel T; Feldmann H
PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
8. The Inability of Marburg Virus to Cause Disease in Ferrets Is Not Solely Linked to the Virus Glycoprotein.
Schiffman Z; Garnett L; Tran KN; Cao W; He S; Emeterio K; Tierney K; Azaransky K; Strong JE; Banadyga L
J Infect Dis; 2023 Nov; 228(Suppl 7):S594-S603. PubMed ID: 37288605
[TBL] [Abstract][Full Text] [Related]
9. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
Ruedas JB; Arnold CE; Palacios G; Connor JH
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890
[TBL] [Abstract][Full Text] [Related]
10. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
[TBL] [Abstract][Full Text] [Related]
11. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.
Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS
PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950
[TBL] [Abstract][Full Text] [Related]
12. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
13. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
Chandran K; Sullivan NJ; Felbor U; Whelan SP; Cunningham JM
Science; 2005 Jun; 308(5728):1643-5. PubMed ID: 15831716
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of filamin A and B proteins in modulating filovirus entry.
Shepley-McTaggart A; Liang J; Ding Y; Djurkovic MA; Kriachun V; Shtanko O; Sunyer O; Harty RN
PLoS Pathog; 2023 Aug; 19(8):e1011595. PubMed ID: 37585478
[TBL] [Abstract][Full Text] [Related]
15. [Ebola and Marburg viruses: the humans strike back].
Alazard-Dany N; Ottmann Terrangle M; Volchkov V
Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Ebola Virus Entry Into Macrophages.
Dahlmann F; Biedenkopf N; Babler A; Jahnen-Dechent W; Karsten CB; Gnirß K; Schneider H; Wrensch F; O'Callaghan CA; Bertram S; Herrler G; Becker S; Pöhlmann S; Hofmann-Winkler H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S247-57. PubMed ID: 25877552
[TBL] [Abstract][Full Text] [Related]
17. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
18. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
Lennemann NJ; Dillard J; Ruggio N; Cooney AL; Schaack GA; Davey RA; Maury W
J Virol; 2021 Aug; 95(18):e0107321. PubMed ID: 34232742
[TBL] [Abstract][Full Text] [Related]
19. Structural and Energetic Basis for Differential Binding of Ebola and Marburg Virus Glycoproteins to a Bat-Derived Niemann-Pick C1 Protein.
Igarashi M; Hirokawa T; Takada A
J Infect Dis; 2023 Nov; 228(Suppl 7):S479-S487. PubMed ID: 37119290
[TBL] [Abstract][Full Text] [Related]
20. Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
Radoshitzky SR; Warfield KL; Chi X; Dong L; Kota K; Bradfute SB; Gearhart JD; Retterer C; Kranzusch PJ; Misasi JN; Hogenbirk MA; Wahl-Jensen V; Volchkov VE; Cunningham JM; Jahrling PB; Aman MJ; Bavari S; Farzan M; Kuhn JH
J Virol; 2011 Sep; 85(17):8502-13. PubMed ID: 21697477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
